In the management of several common neurosurgical conditions, particularly in brain tumours, in subarachnoid haemorrhage and in head injury, it is often difficult to predict during the early phase the probable degree of permanent structural brain damage caused by the disease process and by the therapeutic operative neurosurgical intervention. It is known from previous work of the authors' 2 and others34 that nervous system specific antigens may be released by trauma, stroke and demyelinating disease and their immunoreactivity determined by sensitive quantitive radioimmunoassay (RIA) in serum. In this study an assessment has been made of the correlation between, on the one hand, the early clinical evaluation and the late clinical outcome, and on the other hand the serum levels of immunoreactivity for myelin basic protein. This 
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Discussion
The results suggest that cerebral damage associated with intracranial tumour and cerebrovascular accident, as well as head injury, can lead to significantly 
